HEALWELL Acquires Majority Stake in Mutuo Health Solutions
Toronto, Ontario—HEALWELL AI Inc. has announced that it has acquired a 51% controlling interest in Mutuo Health Solutions, a Toronto-based company specializing in medical artificial intelligence. The deal, valued at $5.5 million, includes cash and shares of HEALWELL.
Mutuo Health is known for its innovative AutoScribe platform, which provides a cutting-edge solution for clinical documentation. This AI-powered tool efficiently transcribes conversations between healthcare providers and patients into high-quality electronic medical records in real time. Using advanced technologies like natural language processing and machine learning, AutoScribe enhances the way medical data is recorded.
The AutoScribe platform stands out for its speech recognition features, designed to prioritize patient privacy. This technology helps healthcare providers to focus more on their patients rather than getting bogged down by paperwork, reducing administrative tasks, and improving care delivery.
HEALWELL plans to integrate AutoScribe with its own AI-enabled decision support systems. This merger aims to create a new suite of virtual assistants for physicians, enhancing their efficiency and effectiveness in patient care.
Founded in 2018, Mutuo was created by a group of AI researchers and healthcare professionals. The team sought to address the challenge of documentation fatigue that many clinicians experience. Mutuo’s development of AutoScribe was part of a collaborative effort with the University of Toronto and Unity Health Toronto, emphasizing its commitment to secure, precision-based, and integrated solutions within the Canadian healthcare system.
Dr. Alexander Dobranowski, CEO of HEALWELL, expressed enthusiasm about the acquisition, highlighting its potential to improve patient care. He noted that AutoScribe’s real-time transcription capabilities will provide clinicians with valuable support, allowing them to focus more on delivering quality care.
Dr. Noah Crampton, CEO of Mutuo Health Solutions, also shared his excitement about the partnership, stating that the collaboration with HEALWELL will help bring AutoScribe to more healthcare providers, reducing the administrative workload for doctors and enhancing patient care quality.
HEALWELL’s focus is on using artificial intelligence to improve early disease detection and clinical efficiency. The company is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under "HWAIF." For more information about HEALWELL, visit their website.
